Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
9
×
life sciences
boston blog main
startups
biotech
boston top stories
new york blog main
new york top stories
san francisco blog main
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle top stories
venture capital
wisconsin blog main
wisconsin top stories
abbvie
amgen
biogen
clinical trials
gilead sciences
indiana blog main
indiana top stories
novartis
pfizer
adverum biotechnologies
alzheimer's disease
astrazeneca
What
ceo
9
×
bio
drug
roundup
acquisitions
medicines
week
announced
big
biggest
crispr
daniel
gilead
medical
medicine
moves
new
o’day
sciences
year
aces
acquisition
aims
albert
amazon’s
athena
backed
biotech
bosley's
bosley’s
bourla
bridge
bucks
build
buy
cancer
cas
cause
chief
cholesterol
Language
unset
unknown
Current search:
ceo
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play
@xconomy.com
5 years ago
Get Physical: Houston’s Kanthaka Offers Personal Trainers in an Hour